Reducing Depression In Seniors ( Two recent studies found to offer good ...)

Reducing Depression In Seniors

Two recent studies found to offer good news for older adults .The first study examined whether home-based programs can reduce depression // in the elderly. Researchers studied nearly 140 adults over age 60. About half of the participants suffered from major depression, while the other half suffered from minor depression. Most of the older adults lived alone and had an annual income of less than $10,000.

Results of the study show seniors who received the home-based program reported fewer depressive symptoms than those who did not receive the intervention. The program consisted of visits and phone calls from a therapist as well as treatment that encouraged the seniors to increase their physical activity and become more social. After one year, participants who received the intervention were about five-times more likely to have at least a 50-percent reduction in depressive symptoms and nearly five-times more likely to achieve complete remission from depression.

The second study examined how long it takes for older individuals to recover from disabling events. Researchers found about four out of five newly disabled seniors regain the ability to live independently within six months of their disabling episode. Researchers say this recovery rate is higher than previously reported.

Thus researchers say only short-term success was observed in the seniors and they feel more needs to be done to prevent disability and disability recurrence.

Page: 1
Related medicine news :

1. Reducing Lung Cancer Risk
2. Reducing the risk for type 2 diabetes
3. Reducing Medication Errors
4. Reducing HIV Transmission
5. Reducing Pain from Knee Surgery
6. Reducing Pain From Knee Surgery
7. Reducing The After Effects of Tonsillectomy
8. Antiparasitic Drug Effective In Reducing Seizures In Neurocysticercosis Patients
9. Reducing Number Of Cigarettes Not Enough
10. Drug Found Effective In Reducing Vertebral Fractures In Women
11. Reducing TB With Ultraviolet Light

Post Your Comments:

(Date:7/18/2008)...state-of-the-art radiation technology ...ER, Texas, July 18 /PRNewswire/ -- Patients of Tri...as Oncology-Tyler are among the first,in the natio...ipment that,provides faster and more accurate trea...p://www.newscom.com/cgi-bin/prnh/20061117/DAF023LO...

(Date:7/18/2008)...the University of Pennsylvania School of Medicine ...ed with familial Alzheimer,s disease disrupt the f...ns, called PS1 and PS2 (presenilin 1 and 2), inter...ular cell compartment. , "The ,calcium dysregula...al Alzheimer,s disease has been suggested by previ...

(Date:7/18/2008)...istance to chemotherapy drugs, sometimes abruptly,...ing well to reduce tumors or hold them in check? ...lt when this occurs is all too familiar: patients ...ecome resistant. , A team of researchers at Cold...stand the genetic underpinnings of cancer therapy ...

(Date:7/18/2008)...wswire-USNewswire/ -- William S.,Harris, Ph.D., FA...ter,dated July 16:, Eating fish, especially oily...heart disease prevention. Fish is low in total and...ce minerals, and contains,long-chain omega-3 fatty...thy omega-3s include salmon, trout, albacore tuna,...

Breaking Medicine News(10 mins):Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 2 Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 3 Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 4 Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 5 Health News:Calcium may be the key to understanding Alzheimer's disease 2 Health News:Calcium may be the key to understanding Alzheimer's disease 3 Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 2 Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 3 Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 4 Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 2 Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 3

[0] Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology [0] Calcium may be the key to understanding Alzheimer's disease [0] CSHL scientists correlate enzyme expression levels with chemotherapy drug response [0] An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008)

...s who are training for marathon running events may...ia (EAH) that can develop from low levels of sodiu...ened when the athletes drink excess amounts of flu... is increasing, but athletes, coaches, and medical...

...ving 3,189 school children from Denmark, Estonia a...ilies don’t necessarily have worse health compared...ucated parents. The results of the study were publ...the study challenge the results of the earlier rep...

...ear of marriage a wife may be able to control how ...abuse like the use of marijuana. However the rever...ollected showed that in the first year of marriage... likely to start or resume smoking marijuana if th...

...nning a pregnancy take a general multivitamin supp...t thing for them and their baby, however a recent ...development defects in unborn babies but many wome...multivitamin supplements say researchers based on ...

Other Medicine News:Health News:Athletes Warned Of Exercise-Associated Hyponatremia 2 Health News:Wife May Determine Husband’s Marijuana Use 2

Athletes Warned Of Exercise-Associated Hyponatremia Junk Food Causes High Level Of Insulin Resistance In Children Wife May Determine Husband’s Marijuana Use The Dangers Of Vitamin A To Pregnant Women To Be Included On Label

(Date:7/16/2008)... Raptor to Support Phase 2a Clinical Trial at UCSD...-- Raptor,Pharmaceuticals Corp. ("Raptor" or the "...ced the execution of a collaboration agreement (th...San Diego ("UCSD") to,include a Phase 2a clinical ... cysteamine bitartrate ("Cysteamine") in adolescen...

(Date:7/15/2008)... Fund Completion of Phase III Trials of Light Infu...tatic Colorectal Cancer and Phase I/II a... BELLEVUE, Wash., July 15 /- Light S...pany developing Light Infusion Therapy(TM),(Litx(T...nounced that it,has raised $40.1 million in a Seri...

(Date:7/15/2008)...Reports 92 Percent Response Rate to Combination Tr...ll/ -- Cephalon, Inc. (Nasdaq:,CEPH) announced tod...in the,Journal of Clinical Oncology, 92 percent of... cell non-Hodgkin,s lymphoma (NHL) responded to tr...e) for Injection plus rituximab.,This combination ...

(Date:7/14/2008)... VIEW, Calif., July 14 /- M...nounced it has initiated its,Phase 3 clinical prog...or,migraine., MAP0004 is orally inhaled and self-...oprietary Tempo(R) inhaler. In the company,s prior...ief in as fast as 10 minutes,with relief sustaine...

[0] Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease [0] Light Sciences Oncology Raises $40.1 Million in Series C Financing [0] Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma [0] MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

...ne 4, 2007 – Data presented,today at this ye...ASCO) meeting in Chicago show that a novel combina...uorouracil (5-FU) therapy UFT,(tegafur–uraci...ponse rate in the first-line treatment of metastat...(Study of CPT-11 with Oxaliplatin combined,with UF...

...ne 4, 2007 – Genta,Incorporated (Nasdaq: GNT...ase 2 clinical trial of its marketed product, Gani...b (Rituxan®;,Genentech/IDEC) and dexamethasone...in’s lymphoma (NHL). The data were,presented...Clinical,Oncology (ASCO) in Chicago, IL. , ,Previo...

Other Medicine Technology:Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 2 Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 3 Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2 Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3 Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4 Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5

Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO

...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...

Medicine Products:

Culture, Mycoplasma pneumoniae Culture, Mumps Culture, Corynebacterium diphtheriae Culture, Bone Marrow

( Two recent studies found to offer good ...)Reducing Depression In Seniors,Health